A Master Protocol of Multiple Interventions for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis.

by | Jun 13, 2025 | Clinical Trials | 0 comments

​ Conditions: Atopic Dermatitis

Interventions: Drug: LY3454738

Sponsors: Eli Lilly and Company

Terminated Conditions: Atopic Dermatitis
Interventions: Drug: LY3454738
Sponsors: Eli Lilly and Company
Terminated 

Submit a Comment

Your email address will not be published. Required fields are marked *